Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
The New England Journal of Medicine|April 30, 1981
A comparison of trimethoprim-sulfamethoxazole plus nystatin with gentamicin plus nystatin in the prevention of infections in acute leukemiaJ C Wade, S C Schimpff, M T Hargadon, et al.
The American Journal of Medicine|December 1, 1981
Piperacillin or ticarcillin plus amikacin. A double-blind prospective comparison of empiric antibiotic therapy for febrile granulocytopenic cancer patientsJ C Wade, S C Schimpff, K A Newman, et al.
Clinical Pharmacy|November 1, 1982
Ototoxicity and pharmacokinetically determined dosages of amikacin in granulocytopenic cancer patientsF J Danhauer, C L Fortner, S C Schimpff, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1977
Amikacin and cephalothin: empiric regimen for granulocytopenic cancer patientsD M Hahn, S C Schimpff, V M Young, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1978
Infection in acute leukemia patients receiving oral nonabsorable antibioticsD M Hahn, S C Schimpff, C L Fortner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2000
A phase I and pharmacologic evaluation of the DNA intercalator CI-958 in patients with advanced solid tumorsE C Dees, L R Whitfield, W R Grove, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1976
Ticarcillin in combination with cephalothin or gentamicin as empiric antibiotic therapy in granulocytopenic cancer patientsS C Schimpff, S Landesman, D M Hahn, et al.
Annals of Internal Medicine|March 1, 1975
Infection prevention in acute nonlymphocytic leukemia. Laminar air flow room reverse isolation with oral, nonabsorbable antibiotic prophylaxisS C Schimpff, W H Greene, V M Young, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1980
Potential of mezlocillin as empiric single-agent therapy in febrile granulocytopenic cancer patientsJ C Wade, S C Schimpff, K A Newman, et al.
Cancer Treatment Reports|February 1, 1985
Phase II trial of diaziquone in patients with colon cancerJ A Neidhart, C Erlichman, F Robert, et al.
Pageof 5